Applied Clinical Trials Magazine

Home
United States
Cranbury, NJ
Applied Clinical Trials Magazine

Call Directions Website Contact the practice

Your Trusted Clinical Trials Management Resource

10/21/2026

Operation TrialBlazer could make the US a faster place to start early-phase trials, with expedited IND pathways and streamlined phase 1 requirements.

Experts break down what's changing in this webinar sponsored by IQVIA.

See what it means for your next phase 1: https://hubs.li/Q04zjp9l0

10/19/2026

More trial data doesn’t automatically mean more insight. Without a plan for what matters, extra data adds duplication, queries, and review burden that slow decisions down.

This webinar, drawing on IQVIA’s eCOA & eSource approaches, lays out four tests every data source should pass. It also shows how cutting transcription gets critical data to study teams sooner.

Get the framework for a connected, digital-first data strategy: https://hubs.li/Q04B0lL50

10/15/2026

If US phase 1 timelines get shorter, is your trial strategy ready?

IQVIA and expert speakers share the steps sponsors can take now under Operation TrialBlazer.

Get the action plan: https://hubs.li/Q04zjq2T0

09/22/2026

Clinical development has slowed by two years over the past decade. The culprits: growing protocol complexity, more amendments, tougher regulatory demands, and harder recruitment.

IQVIA is closing that gap are shifting from reactive to predictive. That means using early engagement, real-world evidence, and AI-enabled intelligence to make development decisions with more confidence, and reducing the "white space" between trials where time quietly gets lost.

This webinar breaks down a practical framework for identifying the risks and inefficiencies that most commonly delay programs, and how to build a faster, more connected path to patients.

Register now: https://hubs.li/Q04xnJG-0

09/16/2026

Clinical development programs now take two years longer than they did a decade ago. Rising complexity, protocol amendments, regulatory demands, and recruitment challenges are all adding up.

Join IQVIA to explore practical ways sponsors can identify risks earlier, reduce delays within and between trials, and improve ex*****on across the development lifecycle.

You'll walk away with a framework for spotting the decisions and inefficiencies that most commonly slow programs down, and insight into how early engagement, real-world evidence, and AI-enabled intelligence can accelerate the path forward.

Register now: https://hubs.li/Q04xnHqQ0

07/07/2026

As protocol complexity grows and enrolment timelines tighten, choosing countries based on patient availability alone can expose sponsors to costly delays, underperforming sites, and increased ex*****on risk.

The question is no longer where are the patients? It's which sites are truly ready to deliver?

Join IQVIA's upcoming webinar to learn how sponsors can pressure test country decisions, assess real-world site readiness, and deploy targeted engagement strategies that strengthen performance before enrolment begins.

Don't wait until timelines are at risk; discover a smarter approach to global clinical trial expansion.

Register today: https://hubs.li/Q04m-2KB0

06/30/2026

Too often, clinical trial expansion decisions start with one question: Where are the patients?

But patient availability alone doesn't guarantee enrolment success.

As sponsors expand into new countries, they're facing a growing challenge: experienced investigators, site readiness, and operational infrastructure don't always exist where patient populations do. The result? Delayed start-up, increased site burden, and missed enrolment goals.

Join our upcoming webinar to explore how a patient population-first strategy can help sponsors make smarter country decisions, reduce ex*****on risk, and improve trial performance from the start.

You'll learn:
✔️ Why patient counts don't tell the full story
✔️ How to evaluate country and site readiness before activation
✔️ Practical strategies to strengthen site capability and protect enrolment timelines

Register now: https://hubs.li/Q04mZdGy0

06/10/2026

Tomorrow: Discover how AI-powered Protocol Ingestion can accelerate study budget development.

See a live demo of how CTFS GrantPlan helps teams reduce manual data entry, improve accuracy, and streamline budgeting workflows through AI-assisted protocol extraction.

Register now: https://hubs.li/Q04hxVSm0

06/09/2026

Representation requires more than recruitment. What comes next?

In part three of this series, Andrelia Allen and Rebecca Johnson, PhD, of Merck discuss the operational realities of expanding access, strengthening community relationships, and creating long-term engagement beyond a single study.

What operational changes do you believe would have the greatest impact on trial representation?

Watch part three in the comments 👇

06/05/2026

How can the industry build greater trust and awareness around clinical trials?

Part two of this series features Andrelia Allen and Rebecca Johnson, PhD, of Merck discussing key considerations around representation in clinical trials and community engagement.

Watch part two in the comments 👇

Address

2 Clarke Drive #100
Cranbury, NJ
08512

Telephone

+16097167777

Website

https://www.mjhlifesciences.com/contact/

Alerts

Be the first to know and let us send you an email when Applied Clinical Trials Magazine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Applied Clinical Trials Magazine:

Want your practice to be the top-listed clinic in Cranbury?